We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Diagnosis of Cancer Using Breath Samples

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01234987
Recruitment Status : Completed
First Posted : November 4, 2010
Last Update Posted : October 28, 2011
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to collect breath samples from healthy and cancer sick patients. The breath, collected to special bags, will be transferred to laboratories in the Technion and analyzed using an electronic nose system developed in Hossam Haick's labs (Chemical Engineering, Technion). The hypothesis is that based on the analysis of the chemical bio-markers present in the exhaled breath, cancer states can be distinguished from healthy subjects or before and after treatment, allowing a technique for diagnosis of cancer and/or cancer treatment.

Condition or disease

Study Design

Study Type : Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Diagnosis of Cancer Using Breath Samples
Groups and Cohorts

Breast cancer
Colon cancer
Lung Cancer

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
People that undergo screening for breast, colon or lung cancers people diagnosed with breast, colon or lung cancers

Inclusion Criteria:

  • The cancer is local or homeostatic
  • The subject did not undergo surgery for tumor removal, chemotherapy or radiation treatment prior to first sampling
  • The subject signed an informed consent form

Exclusion Criteria:

  • The subject is addicted to drugs or alcohol
  • The subject smoked in the last hour
  • There are communication problems with the subject
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01234987

Rambam Health Care Campus
Haifa, Israel, 31096
Sponsors and Collaborators
Technion, Israel Institute of Technology
Rambam Hospital
More Information

ClinicalTrials.gov Identifier: NCT01234987     History of Changes
Other Study ID Numbers: DCHHSGCTIL
First Posted: November 4, 2010    Key Record Dates
Last Update Posted: October 28, 2011
Last Verified: December 2010

Keywords provided by Technion, Israel Institute of Technology:
Breast Cancer
Colon cancer
Lung Cancer